NASDAQ:URGN

UroGen Pharma SEC Filings & 10K Form

$18.22
+0.18 (+1.00 %)
(As of 05/7/2021 12:00 AM ET)
Add
Compare
Today's Range
$17.90
$18.73
50-Day Range
$17.48
$20.94
52-Week Range
$17.01
$30.89
Volume58,350 shs
Average Volume185,345 shs
Market Capitalization$380.74 million
P/E RatioN/A
Dividend YieldN/A
Beta1.32

SEC Filings

UroGen Pharma (NASDAQ:URGN) SEC Filings

DateFilerForm TypeView
05/04/2021
12:58 PM
Schoenberg Mark (Reporting)
Schoenberg Mark (Reporting)
UroGen Pharma (Issuer)
UroGen Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/27/2021
12:44 PM
Schoenberg Mark (Reporting)
UroGen Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/22/2021
4:19 PM
Belldegrun Arie (Reporting)
UroGen Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/22/2021
4:18 PM
Nussbaum Ran (Reporting)
UroGen Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2021
7:13 AM
UroGen Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/18/2021
7:10 AM
UroGen Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/18/2021
7:10 AM
UroGen Pharma (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/11/2021
6:28 AM
MENORA MIVTACHIM HOLDINGS LTD. (Filed by)
UroGen Pharma (Subject)
Form SC 13G/A
02/03/2021
12:13 PM
UroGen Pharma (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
02/02/2021
2:55 PM
Smith Jason Drew (Reporting)
UroGen Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2021
1:54 PM
Barrett Elizabeth A. (Reporting)
UroGen Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2021
1:53 PM
Schoenberg Mark (Reporting)
UroGen Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/01/2021
7:17 AM
BlackRock Inc. (Filed by)
UroGen Pharma (Subject)
Form SC 13G/A
01/26/2021
4:20 PM
Schoenberg Mark (Reporting)
UroGen Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2021
7:03 AM
UroGen Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/11/2021
7:31 AM
UroGen Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/15/2020
4:27 PM
Barrett Elizabeth A. (Reporting)
UroGen Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/07/2020
2:59 PM
Schoenberg Mark (Reporting)
UroGen Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/04/2020
3:35 PM
Barrett Elizabeth A. (Reporting)
UroGen Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/03/2020
3:05 PM
UroGen Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/17/2020
3:15 PM
UroGen Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/09/2020
7:13 AM
UroGen Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/09/2020
6:40 AM
UroGen Pharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/28/2020
1:12 PM
Schoenberg Mark (Reporting)
UroGen Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/16/2020
2:41 PM
PFREUNDSCHUH PETER P. (Reporting)
UroGen Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/05/2020
3:37 PM
Henderson Molly (Reporting)
UroGen Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/05/2020
3:36 PM
Henderson Molly (Reporting)
UroGen Pharma (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
10/05/2020
3:35 PM
Smith Jason Drew (Reporting)
UroGen Pharma (Issuer)
Form 4/A
09/10/2020
11:14 AM
Smith Jason Drew (Reporting)
UroGen Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2020
11:13 AM
Smith Jason Drew (Reporting)
UroGen Pharma (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/09/2020
7:02 AM
UroGen Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/08/2020
3:48 PM
Schoenberg Mark (Reporting)
UroGen Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/01/2020
1:37 PM
PFREUNDSCHUH PETER P. (Reporting)
UroGen Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/27/2020
7:01 AM
UroGen Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/10/2020
4:08 PM
UroGen Pharma (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
08/10/2020
6:35 AM
UroGen Pharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/10/2020
6:20 AM
UroGen Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/28/2020
4:34 PM
PFREUNDSCHUH PETER P. (Reporting)
UroGen Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/28/2020
4:32 PM
Schoenberg Mark (Reporting)
UroGen Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2020
5:43 PM
Tomasello Shawn (Reporting)
UroGen Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2020
5:41 PM
Nussbaum Ran (Reporting)
UroGen Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2020
5:40 PM
Holden Stuart (Reporting)
UroGen Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2020
5:39 PM
FALBERG KATHRYN E (Reporting)
UroGen Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2020
5:38 PM
Cohen Fred E (Reporting)
UroGen Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2020
5:36 PM
BUTITTA CYNTHIA M (Reporting)
UroGen Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2020
5:35 PM
Belldegrun Arie (Reporting)
UroGen Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2020
1:31 PM
Schoenberg Mark (Reporting)
UroGen Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2020
3:44 PM
PFREUNDSCHUH PETER P. (Reporting)
UroGen Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2020
8:17 AM
UroGen Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/14/2020
12:07 PM
Barrett Elizabeth A. (Reporting)
UroGen Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2020
6:03 AM
UroGen Pharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/29/2020
5:53 AM
UroGen Pharma (Filer)
Form DEFA14A
04/29/2020
5:42 AM
UroGen Pharma (Filer)
Form DEF 14A
04/28/2020
12:53 PM
Schoenberg Mark (Reporting)
UroGen Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/28/2020
12:51 PM
PFREUNDSCHUH PETER P. (Reporting)
UroGen Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/28/2020
12:43 PM
Mullennix Stephen (Reporting)
UroGen Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/15/2020
8:29 PM
UroGen Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/23/2020
6:31 AM
UroGen Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/04/2020
4:28 PM
Schoenberg Mark (Reporting)
UroGen Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2020
6:33 AM
UroGen Pharma (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/24/2020
3:53 PM
PFREUNDSCHUH PETER P. (Reporting)
UroGen Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2020
1:33 PM
Mullennix Stephen (Reporting)
UroGen Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2020
3:27 PM
UroGen Pharma (Subject)
Wildcat Capital Management, LLC (Filed by)
Form SC 13G/A
02/13/2020
12:54 PM
Schoenberg Mark (Reporting)
UroGen Pharma (Issuer)
Form 3/A
02/13/2020
12:47 PM
Belldegrun Arie (Reporting)
UroGen Pharma (Issuer)
Form 3/A
02/04/2020
11:40 AM
PFREUNDSCHUH PETER P. (Reporting)
UroGen Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2020
11:39 AM
Mullennix Stephen (Reporting)
UroGen Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2020
11:38 AM
Schoenberg Mark (Reporting)
UroGen Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2020
11:36 AM
Barrett Elizabeth A. (Reporting)
UroGen Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/28/2020
4:15 PM
PFREUNDSCHUH PETER P. (Reporting)
UroGen Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/28/2020
4:14 PM
Mullennix Stephen (Reporting)
UroGen Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/28/2020
4:10 PM
Schoenberg Mark (Reporting)
UroGen Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/27/2020
2:11 PM
UroGen Pharma (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
01/07/2020
5:30 PM
Barrett Elizabeth A. (Reporting)
UroGen Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2020
11:15 PM
UroGen Pharma (Filer)
Form EFFECT
01/02/2020
3:50 PM
UroGen Pharma (Filer)
Form 424B5
12/20/2019
3:31 PM
UroGen Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/05/2019
12:44 PM
Schoenberg Mark (Reporting)
UroGen Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2019
3:16 PM
UroGen Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/22/2019
2:34 PM
Barrett Elizabeth A. (Reporting)
UroGen Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2019
12:35 PM
Barrett Elizabeth A. (Reporting)
UroGen Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2019
12:29 PM
PFREUNDSCHUH PETER P. (Reporting)
UroGen Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2019
7:49 PM
Schoenberg Mark (Reporting)
UroGen Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/18/2019
6:32 PM
Barrett Elizabeth A. (Reporting)
UroGen Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/18/2019
3:04 PM
Mullennix Stephen (Reporting)
UroGen Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2019
7:06 AM
UroGen Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/12/2019
6:32 AM
UroGen Pharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/12/2019
6:01 AM
UroGen Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/08/2019
3:02 PM
UroGen Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/04/2019
3:16 PM
UroGen Pharma (Subject)
Wildcat Capital Management, LLC (Filed by)
Form SC 13G
09/24/2019
4:20 PM
UroGen Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/06/2019
8:27 AM
Schoenberg Mark (Reporting)
UroGen Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2019
12:31 PM
PFREUNDSCHUH PETER P. (Reporting)
UroGen Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/16/2019
2:38 PM
Mullennix Stephen (Reporting)
UroGen Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/09/2019
7:32 AM
UroGen Pharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/09/2019
7:16 AM
UroGen Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/07/2019
4:11 PM
UroGen Pharma (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
06/07/2019
4:00 PM
UroGen Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/06/2019
5:21 PM
Schoenberg Mark (Reporting)
UroGen Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2019
4:02 PM
Tomasello Shawn (Reporting)
UroGen Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
This page was last updated on 5/9/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.